Every modern vaccine and medicine we have today was first studied in clinical trials involving hundreds to thousands of people before becoming available to the public. Previous clinical trials involving this COVID-19 vaccine were not designed to include most patients with compromised immune systems. This trial will help determine how safe and tolerable the COVID-19 study vaccine is for individuals with compromised immune systems, and how well their immune systems respond to the vaccine.
By choosing to volunteer, you will represent people like you with conditions that make them immunocompromised.
Who Can Participate
- Adults at least 18 years of age who have been diagnosed with one of the following:
- Non-Small Cell Lung Cancer
- Chronic Lymphocytic Leukemia
- End-Stage Renal Disease on hemodialysis
- Receiving immunomodulators therapy for an autoimmune inflammatory disorder
- Children 2-4 and adolescents 12-17 years of age for which one of the following is true:
- Receiving immunomodulators therapy for an autoimmune inflammatory disorder
- Are receiving maintenance antirejection medications for an organ transplant
- Have undergone a bone marrow or stem cell transplant
- Participants should not have been previously diagnosed with COVID-19
- Participants should not have already received a COVID-19 vaccine
Note: These are not the only eligibility criteria for this clinical research study. A clinical research team member will help determine if this study is right for your child based on all of the participation criteria.
The number of participants for the 5-11 year -old age group has been reached and is no longer enrolling new participants